If you think about it the CEO's of Pfizer and Moderna had a decision to make over a year ago as to how much mRNA to include in their vaccines. Both knew the facts....the greater the amount of mRNA in each shot the greater the efficacy but higher the risk of side effects (both short and long term). Pfizer chose 30mcg while MRNA chose 100mcg. Wonder why? Consider the fact before COVID Pfizer was a near 300B dollar company with multiple brands while Moderna wasn't even worth 8B with no history of sales. Who faced the greater risk if it turned out the side effects risks were greater than expected? Who stood to gain the most if they weren't? IMO both acted in a reasonable manner (Pfizer taking the conservative route and MRNA the more aggressive one) considering their status of the companies at

I remember when MRNA used to cost around $9 per share, then a few months later I looked at it and it was around $400 per share. I believe PROG has the same potential to reach that high of a level eventually. $69 would be a great price for PROG but I ain't too sure it will be that price later. A stock squeeze can easily go past that with that high of a short interest and CTB.$Progenity, Inc.(PROG)$

DIsney is trying to get into higher growth mode. Buying Star Wars, Marvel, etc and then leveraging them into streaming services. If they were still mostly just parks, cruises, movies then they would still be a slow grower, paying a dividend. Now they are spending in a big way to develop the IPs they have purchased and their streaming services. So they no longer pay a dividend, and instead want growth. Eventually they may pay a dividend again, but I wouldn't expect it for years. Don't get too caught up in dividends anyway. It's not free money. Dividends come out of the company's value, and so when they pay a dividend their share price goes down since they no longer have that cash on their balance sheet.$Walt Disney(DIS)$

Won’t be long before shorts turn on each other and start frantically buying back shares to secure profits. Let’s be honest they’ve made a lot of money shorting BBIG from its ATH. This should reach at least $5 before the dehedging period. Then it’s up to management to release good PR if we want to reach $10+ again. Next year hopefully we’ll see $30-40$Vinco Ventures, Inc.(BBIG)$

Good things are coming for us long term investors, the shorts cannot keep their short positions for too long as the CTB rates are too high and the stock won't go too much lower.The company is working hard on researching the next generation of drug delivery technology to help treat people with various medical conditions (i.e. Arthritis, Pre-eclampsia, etc) as well as medical diagnosis (i.e. using robot pill in place of traditional colonscopy).Progenity are working with multiple companies to achieve their goals and they have plenty of money for operation.Bottom line:Hold strong, the best is yet to come!$Progenity, Inc.(PROG)$

Moderna edges out Pfizer vaccine in head-to-head comparison. Compared with the Pfizer COVID-19 vaccine, the Moderna COVID-19 vaccine has a slightly lower risk of COVID-19 outcomes, including documented SARS-CoV-2 infection, symptomatic COVID-19, and COVID-19-related hospitalization, intensive care unit admission, and death, over a 24-week period, according to a team of researchers. This pattern was consistent for periods when Alpha or Delta were the predominant variant. Moderna is the best vax, be sure your family gets moderna nothing else and insist on mRNA. Moderna is a good deal. $Moderna, Inc.(MRNA)$ $Pfizer(PFE)$

Buckle up, Take off imminent! Will MRNA, BNTX and NVAX continue to fly up to their new high while the other tech stocks keep sinking Moderna Inc. Chief Medical Officer Paul Burton said he suspects the new omicron coronavirus variant may elude current vaccines and, if so, a reformulated shot could be available early next year. Moderna is testing the current vaccine against the new variant and studying two booster candidates.$Moderna, Inc.(MRNA)$ $BioNTech SE(BNTX)$ $Novavax(NVAX)$

It’s likely to settle no lower than $19, once the insiders and MMS buy to cover and load up on shares to pump it to $27. No need to panic sell, the Fed isn’t raising interest rates.$Palantir Technologies Inc.(PLTR)$

Im looking to buy in now. Problem is there are cheaper alternatives that now have reached scale for large organizations that essentially do the same thing. In fact some are free but not scalable for free. Without question digital verification and signature services are going to be the norm. I closed on property without ever physically seeing or signing a contract. It was done digitally with a very low cost competitor. I always liked this company. Just like ZOOM is DOCU also going to fall away because of over inflated numbers due to pandemic? What do you think? Now is certainly the time to enter the stock. There will likely be a bounce.$Docusign(DOCU)$ $Zoom(ZM)$